Press release
Human Vascular Endothelial Growth Factor Antibody Market 2022 Growth, COVID Impact, Trends Analysis Report 2028
The global human vascular endothelial growth factor (VEGF) antibody market is anticipated to grow at a significant CAGR of 10.1% during the forecast period (2022-2028).A Human VEGF antibody is a signal protein that helps in the formation of new blood vessels through a process known as angiogenesis. It is used to create new blood vessels during embryonic development, new blood vessels after injury, muscle following exercise, and new vessels to bypass blocked vessels. The human VEGF antibody market is growing due to the rising prevalence of cancer patients globally. According to the World Health Organization, cancer is a leading cause of death globally, accounting for around 10 million deaths in 2020, or around one in every sixth death.
(Get 15% Discount on Buying this Report)
A full report of Global Human Vascular Endothelial Growth Factor Antibody Market is available at: https://orionmarketreports.com/human-vascular-endothelial-growth-factor-antibody-market/104632/
The rising macular degeneration cases globally are also driving the demand for human VEGF antibodies. According to Macular Degeneration Research by BrightFocus Foundation in July 2021, macular degeneration is a leading cause of vision loss in Americans of age 60 years and above. Around 196 million people are living with macular degeneration globally and it will increase to 288 million by 2040. Additionally, improved healthcare infrastructure, several clinical trials along with huge investment by major market players for improvement in new drug therapies is also driving the demand for the global human VEGF antibody market.
The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new drug launches, to stay competitive in the market. For instance-
• In January 2022, Compass Therapeutics, Inc. received the USFDA clearance of investigational new drug application for a phase-2 study of CTX-009, a bispecific antibody that simultaneously targets delta-like ligand 4 (DLL4) and vascular endothelial growth factor-A.
• In January 2022, the USFDA approved Faricimab, a bispecific monoclonal antibody drug to target two distinct pathways, Ang-2 and VEGF-A, that often cause retinal disease that may lead to vision loss.
• In January 2022, Genentech, Inc. announced the launch of Vabysmo for the treatment of people with wet, or neovascular, age-related macular degeneration (AMD) and diabetic macular edema in the US market.
• In October 2021, F. Hoffmann-La Roche Ltd. received the USFDA approval for Susvimo, a first-of-its-kind therapeutic approach for the treatment of neovascular or wet age-related macular degeneration.
Market Coverage
• The market number available for - 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Eli Lilly and Co., Genentech, Inc., and Ceres Oncology Pty Ltd., among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Human Vascular Endothelial Growth Factor Antibody Market Report by Segment
By Type
• Avastin
• Cometriq
• Eylea
• Jetrea
• Cyramza
• Macugen
• Lucentis
• Others
By Application
• Cancer
• Ophthalmology
• Others
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Vascular Endothelial Growth Factor Antibody Market 2022 Growth, COVID Impact, Trends Analysis Report 2028 here
News-ID: 2616875 • Views: …
More Releases from Orion Market Reports
Foot Care Creams & Lotions Market 2024 Trends with Analysis on Key Players
The Foot Care Creams & Lotions Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2024-2031). Foot care creams and lotions are specialized skincare products formulated to address the unique needs of the feet. These products are designed to moisturize, nourish, soothe, and protect the skin on the feet, helping to keep them soft, smooth, and healthy. Foot care creams and lotions…
Food Machine Market Value Projected to Expand by 2031
The Food Machine Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). "Food machine" is a broad term that encompasses a wide range of machinery and equipment used in the food processing and manufacturing industry. These machines are essential for various stages of food production, from processing raw ingredients to packaging finished products.
Food Machine Market research analyzes the entire market, industry…
Foil Zipper Bags Market Sluggish Growth Rate Foreseen by 2024-2031
The Foil Zipper Bags Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2024-2031). Foil zipper bags are a type of flexible packaging commonly used for storing and preserving various food and non-food items. These bags are made from layers of laminated materials, including aluminum foil, which provide excellent barrier properties against moisture, oxygen, light, and odors. The zipper closure allows for…
Home Trampoline Market is Anticipated to Increase at a Stable CAGR over the Fore …
The Home Trampoline Market size is expected to grow at an annual average of CAGR 3% during the forecast period (2024-2031). A home trampoline is a recreational device designed for use in residential settings, typically in the backyard or a designated indoor space. It consists of a strong, flexible fabric stretched tightly over a steel frame using coiled springs or elastic bands to provide bounce. Home trampolines come in various…
More Releases for VEGF
Anti-VEGF Therapeutics Market In-Deep Research and Forecast Report
The revenue of the anti-VEGF therapeutics market will increase from $12,178.0 million in 2021 at a compound annual growth rate of 1.4% from 2021 to 2030, to touch $13,812.6 million by 2030. The development of the industry is mainly driven by the approvals of the FDA to a number of drug candidates, accompanied by R&D activities.
Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/anti-vascular-endothelial-growth-factor-therapeutics-market/report-sample
Eylea held the largest share in the…
(Post-pandemic Era) - VEGF Antibody Market Future Developments and Industry Size …
According to Research study, over the next 5 years the (Post-pandemic Era) - VEGF Antibody market will register a xx% CAGR in terms of revenue, the global market size will reach xx Million USD by 2026, from xx Million USD in 2020. In particular, it should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply…
Global VEGF/VEGFR Inhibitor Drugs Industry Research Analysis by 2020- 2025
This report also researches and evaluates the impact of Covid-19 outbreak on the VEGF/VEGFR Inhibitor Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on VEGF/VEGFR Inhibitor Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
GLOBAL INFO RESEARCH has lately published a new report titled, *Global and Japan VEGF/VEGFR Inhibitor Drugs Market 2020 by Company, Type and Application, Forecast to…
Vascular Endothelial Growth Factor (VEGF) Antibodies Market By 2026 Genentech, N …
Vascular Endothelial Growth Factor (VEGF) is a signal protein that helps in the formation of new blood vessels through a process known as angiogenesis. Vascular endothelial growth factor is a part of several pathological processes and researches are often carried out for the development of novel therapies using these factors for diseases such as cancer. Normal functions of vascular endothelial growth factor includes embryonic development, formation of new blood vessels,…
Vascular Endothelial Growth Factor (VEGF) Antibodies Market Opportunity Analysis …
Vascular Endothelial Growth Factor (VEGF) is a signal protein that helps in the formation of new blood vessels through a process known as angiogenesis. Vascular endothelial growth factor is a part of several pathological processes and researches are often carried out for the development of novel therapies using these factors for diseases such as cancer. Normal functions of vascular endothelial growth factor includes embryonic development, formation of new blood vessels,…
Vascular Endothelial Growth Factor (VEGF) Antibodies Market Report Explored in L …
Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market: Overview
Vascular endothelial growth factor is an integral part of several pathophysiological processes. This is the primary reason why it is extensively used for designing therapies to treat patients with macular degeneration and cancers. The global vascular endothelial growth factor (VEGF) antibodies is gaining momentum as it is known to be far more effective than conventional pharmaceuticals.
Currently, VEGF antibodies used for treating…
